Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurocognitive Empowerment for Addiction Treatment (NEAT) in People With Opioid Use Disorder and Amphetamine Use Disorder: A Randomized Clinical Trial

NCT03922646 is registered in ClinicalTrials.gov with Laureate Institute for Brain Research, Inc. as lead sponsor.

NCT NCT03922646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03922646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurocognitive Empowerment for Addiction Treatment (NEAT) in People With Opioid Use Disorder and Amphetamine Use Disorder: A Randomized Clinical Trial
Lead sponsor
Laureate Institute for Brain Research, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 6, 2019
Completion date
May 12, 2023
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amphetamine use disorders, opioid-use disorder